Company Profiles

driven by the PitchBook Platform

Allecra Therapeutics

Description

Developer of novel antibiotics to combat Gram-negative bacterial infections. The company has developed products intended to treat multi-drug-resistant infections.

2013

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$24.9M

Latest Deal Amount

$44.4M

Total Amount Raised

Description

Developer of novel antibiotics to combat Gram-negative bacterial infections. The company has developed products intended to treat multi-drug-resistant infections.

Website:

www.allecra.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals

Primary Office

Im Kränzliacker 9 79576 Weil am RheinGermany +49 (0)79 5922 005
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Allecra Therapeutics's full profile, request a free trial.

Allecra Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Allecra Therapeutics Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Delos Capital (Hong Kong)Venture CapitalMinority000 0000000 0000
Edmond de Rothschild Investment PartnersPE/BuyoutMinority000 0000000 0000
EMBL VenturesVenture CapitalMinority000 0000000 0000
Forbion Capital PartnersVenture CapitalMinority000 0000000 0000
Orchid PharmaVC-Backed CompanyMinority000 0000000 0000
Delos Capital (Hong Kong) Venture Capital
Edmond de Rothschild Investment Partners PE/Buyout
EMBL Ventures Venture Capital
Forbion Capital Partners Venture Capital
Orchid Pharma VC-Backed Company

Allecra Therapeutics Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Nicholas BenedictCo-Founder & Chief Executive Officer
Brice SuireChief Financial Officer
Omar Lalhou Ph.DDirector, Regulatory Affairs
Stefano BiondiHead of Chemistry, Manufacturing and Controls
Marcin Mankowski MDChief Medical Officer
Nicholas Benedict Co-Founder & Chief Executive Officer
Brice Suire Chief Financial Officer
Omar Lalhou Ph.D Director, Regulatory Affairs
Stefano Biondi Head of Chemistry, Manufacturing and Controls
Marcin Mankowski MD Chief Medical Officer

Allecra Therapeutics Board Members (4)

NameRepresentingRoleSinceContact
Info
Henry Chen JDDelos Capital (Hong Kong)Co-Founder & Managing Partner000 0000
Holger Reithinger Ph.DForbion Capital PartnersGeneral Partner000 0000
Olivier Litzka Ph.DEdmond de Rothschild Investment PartnersPartner000 0000
Tim XiaoDelos Capital (Hong Kong)Vice President000 0000
Henry Chen JD Co-Founder & Managing Partner Delos Capital (Hong Kong)
Holger Reithinger Ph.D General Partner Forbion Capital Partners
Olivier Litzka Ph.D Partner Edmond de Rothschild Investment Partners
Tim Xiao Vice President Delos Capital (Hong Kong)
Request full access to PitchBook